Tiffany Thorn
Fundador en BIVICTRIX THERAPEUTICS PLC .
Fortuna: 235 080 $ al 30/04/2024
Cargos activos de Tiffany Thorn
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Director/Miembro de la Junta | 01/01/2016 | - |
| Director Ejecutivo | 01/01/2016 | - | |
| Fundador | 01/01/2016 | - |
Historial de carrera de Tiffany Thorn
Antiguos cargos conocidos de Tiffany Thorn.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MOTIF BIO PLC | Director/Miembro de la Junta | 14/06/2021 | - |
| Director Ejecutivo | 14/06/2021 | - |
Formación de Tiffany Thorn.
| The University of Manchester | Graduate Degree |
| University of Lancaster | Undergraduate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Israel | 2 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIVICTRIX THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Tiffany Thorn
- Experiencia
